Cargando…
Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
Peroxisome proliferator-activated receptor alpha (PPARA) has been suggested as a therapeutic target for chronic lymphocytic leukemia (CLL). However, the underlying molecular mechanism remains largely unclear. In this study, we analyzed DNA next-generation sequencing (NGS) data and clinical informati...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317583/ https://www.ncbi.nlm.nih.gov/pubmed/37404899 http://dx.doi.org/10.1155/2023/8456833 |
_version_ | 1785067896907497472 |
---|---|
author | Xiang, Xixi Li, Fu Zhou, Sha Zeng, Yunjing Deng, Xiaojuan Zhang, Hongyang Li, Jiali Liu, Hongyun Rao, Jun Gao, Lei Zhang, Cheng Wen, Qin Gao, Li Zhang, Xi |
author_facet | Xiang, Xixi Li, Fu Zhou, Sha Zeng, Yunjing Deng, Xiaojuan Zhang, Hongyang Li, Jiali Liu, Hongyun Rao, Jun Gao, Lei Zhang, Cheng Wen, Qin Gao, Li Zhang, Xi |
author_sort | Xiang, Xixi |
collection | PubMed |
description | Peroxisome proliferator-activated receptor alpha (PPARA) has been suggested as a therapeutic target for chronic lymphocytic leukemia (CLL). However, the underlying molecular mechanism remains largely unclear. In this study, we analyzed DNA next-generation sequencing (NGS) data and clinical information from 86 CLL patients to identify gene markers related to treatment-free survival (TFS) length. We then constructed a genetic network that includes CLL promoters, treatment targets, and TFS-related marker genes. To assess the significance of PPARA within the network, we utilized degree centrality (DC) and pathway enrichment score (EScore). Clinical and NGS data revealed 10 TFS length-related gene markers, including RPS15, FOXO1, FBXW7, KMT2A, NOTCH1, GNA12, EGR2, GNA13, KDM6A, and ATM. Through literature data mining, 83 genes were identified as CLL upstream promoters and treatment targets. Among them, PPARA exhibited a stronger connection to CLL and TFS-related gene markers, as evidenced by its ranking at No. 13 based on DC, compared to most of the other promoters (>84%). Additionally, PPARA co-functions with 70 out of 92 in-network genes in various functional pathways/gene groups related to CLL pathology, such as regulation of cell adhesion, inflammation, reactive oxygen species, and cell differentiation. Based on our findings, PPARA is considered one of the critical genes within a large genetic network that influences the prognosis and TFS of CLL through multiple pathogenic pathways. |
format | Online Article Text |
id | pubmed-10317583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-103175832023-07-04 Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia Xiang, Xixi Li, Fu Zhou, Sha Zeng, Yunjing Deng, Xiaojuan Zhang, Hongyang Li, Jiali Liu, Hongyun Rao, Jun Gao, Lei Zhang, Cheng Wen, Qin Gao, Li Zhang, Xi PPAR Res Research Article Peroxisome proliferator-activated receptor alpha (PPARA) has been suggested as a therapeutic target for chronic lymphocytic leukemia (CLL). However, the underlying molecular mechanism remains largely unclear. In this study, we analyzed DNA next-generation sequencing (NGS) data and clinical information from 86 CLL patients to identify gene markers related to treatment-free survival (TFS) length. We then constructed a genetic network that includes CLL promoters, treatment targets, and TFS-related marker genes. To assess the significance of PPARA within the network, we utilized degree centrality (DC) and pathway enrichment score (EScore). Clinical and NGS data revealed 10 TFS length-related gene markers, including RPS15, FOXO1, FBXW7, KMT2A, NOTCH1, GNA12, EGR2, GNA13, KDM6A, and ATM. Through literature data mining, 83 genes were identified as CLL upstream promoters and treatment targets. Among them, PPARA exhibited a stronger connection to CLL and TFS-related gene markers, as evidenced by its ranking at No. 13 based on DC, compared to most of the other promoters (>84%). Additionally, PPARA co-functions with 70 out of 92 in-network genes in various functional pathways/gene groups related to CLL pathology, such as regulation of cell adhesion, inflammation, reactive oxygen species, and cell differentiation. Based on our findings, PPARA is considered one of the critical genes within a large genetic network that influences the prognosis and TFS of CLL through multiple pathogenic pathways. Hindawi 2023-06-26 /pmc/articles/PMC10317583/ /pubmed/37404899 http://dx.doi.org/10.1155/2023/8456833 Text en Copyright © 2023 Xixi Xiang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Xiang, Xixi Li, Fu Zhou, Sha Zeng, Yunjing Deng, Xiaojuan Zhang, Hongyang Li, Jiali Liu, Hongyun Rao, Jun Gao, Lei Zhang, Cheng Wen, Qin Gao, Li Zhang, Xi Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia |
title | Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia |
title_full | Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia |
title_fullStr | Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia |
title_full_unstemmed | Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia |
title_short | Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia |
title_sort | significance of ppara as a treatment target for chronic lymphocytic leukemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317583/ https://www.ncbi.nlm.nih.gov/pubmed/37404899 http://dx.doi.org/10.1155/2023/8456833 |
work_keys_str_mv | AT xiangxixi significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT lifu significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT zhousha significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT zengyunjing significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT dengxiaojuan significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT zhanghongyang significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT lijiali significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT liuhongyun significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT raojun significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT gaolei significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT zhangcheng significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT wenqin significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT gaoli significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia AT zhangxi significanceofpparaasatreatmenttargetforchroniclymphocyticleukemia |